Reuters logo
CORRECTED-BRIEF-GSK's Revolade gets European approval for additional Hep C indication
September 24, 2013 / 9:48 AM / 4 years ago

CORRECTED-BRIEF-GSK's Revolade gets European approval for additional Hep C indication

(Corrects headline to say Revolade is now approved for additional indication of hepatitis C)

Sept 24 (Reuters) - GlaxoSmithKline Plc : * Receives European marketing approval for additional indication for Revolade * Approval for treatment of low platelet count in adult patients with chronic hepatitis C infection * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below